bis(5-amidino-2-benzimidazolyl)methane has been researched along with Bright Disease in 1 studies
bis(5-amidino-2-benzimidazolyl)methane: aromatic diamidine which has a significant suppressive effect on the cytopathology & yield of respiratory synctial (RS) virus; RN given refers to parent cpd
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jennette, JC | 1 |
| Tidwell, RR | 1 |
| Geratz, JD | 1 |
| Bing, DH | 1 |
| Falk, RJ | 1 |
1 other study available for bis(5-amidino-2-benzimidazolyl)methane and Bright Disease
| Article | Year |
|---|---|
Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.
Topics: Amidines; Animals; Benzimidazoles; Complement Inactivator Proteins; Creatinine; Glomerulonephritis; | 1987 |